St. Clair Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
St. Clair Advisors's GILD Position: Q3 2026 in Review
St. Clair Advisors held its Gilead Sciences (GILD) position steady in Q3 2026 at 5,219 shares worth $778K. The position accounts for 0.19% of the portfolio, ranked #55.
St. Clair Advisors first reported a position in GILD in Q4 2022 and has held it in 16 quarters since. 1,394 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- St. Clair Advisors held 5,219 shares of Gilead Sciences worth $778K as of Q3 2026.
- St. Clair Advisors left its Gilead Sciences share count unchanged in Q3 2026.
- Gilead Sciences made up 0.19% of St. Clair Advisors's portfolio in Q3 2026, its #55 holding.
- St. Clair Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 16 quarters since.
- 1,394 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on St. Clair Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.